FIGS, Inc. (NYSE:FIGS - Get Free Report) CFO Sarah Oughtred sold 9,968 shares of the stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $7.36, for a total transaction of $73,364.48. Following the sale, the chief financial officer directly owned 868,090 shares of the company's stock, valued at approximately $6,389,142.40. This trade represents a 1.14% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
Sarah Oughtred also recently made the following trade(s):
- On Monday, August 4th, Sarah Oughtred sold 99,834 shares of FIGS stock. The stock was sold at an average price of $6.19, for a total transaction of $617,972.46.
FIGS Stock Down 1.1%
Shares of FIGS stock traded down $0.08 during trading hours on Monday, hitting $7.03. The company's stock had a trading volume of 1,448,911 shares, compared to its average volume of 2,118,543. The company has a market capitalization of $1.15 billion, a PE ratio of 175.79, a P/E/G ratio of 4.56 and a beta of 1.33. The business has a fifty day moving average of $6.84 and a 200 day moving average of $5.59. FIGS, Inc. has a 1-year low of $3.57 and a 1-year high of $7.54.
FIGS (NYSE:FIGS - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.04 earnings per share for the quarter, topping analysts' consensus estimates of $0.02 by $0.02. FIGS had a return on equity of 1.84% and a net margin of 1.26%.The firm had revenue of $152.64 million during the quarter, compared to analysts' expectations of $144.17 million. During the same quarter in the prior year, the business earned $0.01 EPS. FIGS's quarterly revenue was up 5.8% compared to the same quarter last year. On average, sell-side analysts anticipate that FIGS, Inc. will post 0.01 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in FIGS. Farther Finance Advisors LLC raised its stake in FIGS by 12,795.0% during the 2nd quarter. Farther Finance Advisors LLC now owns 5,158 shares of the company's stock valued at $29,000 after purchasing an additional 5,118 shares during the period. GAMMA Investing LLC lifted its position in shares of FIGS by 585.8% in the first quarter. GAMMA Investing LLC now owns 6,536 shares of the company's stock worth $30,000 after purchasing an additional 5,583 shares in the last quarter. Capstone Financial Advisors Inc. acquired a new position in FIGS in the 2nd quarter valued at approximately $56,000. Hudson Bay Capital Management LP purchased a new stake in FIGS in the 2nd quarter worth approximately $61,000. Finally, Walleye Capital LLC acquired a new stake in shares of FIGS during the 2nd quarter valued at $65,000. 92.21% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on FIGS shares. The Goldman Sachs Group boosted their price target on shares of FIGS from $3.75 to $4.50 and gave the company a "sell" rating in a report on Tuesday, July 22nd. Cowen restated a "hold" rating on shares of FIGS in a research report on Friday, August 8th. Telsey Advisory Group reissued a "market perform" rating and issued a $7.00 price target (up previously from $5.00) on shares of FIGS in a research note on Monday, August 4th. Wall Street Zen cut shares of FIGS from a "strong-buy" rating to a "buy" rating in a research note on Saturday. Finally, Weiss Ratings reiterated a "sell (d+)" rating on shares of FIGS in a research report on Saturday, September 27th. One analyst has rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of "Reduce" and a consensus price target of $5.38.
View Our Latest Stock Analysis on FIGS
About FIGS
(
Get Free Report)
FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider FIGS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FIGS wasn't on the list.
While FIGS currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.